Cantor Fitzgerald analyst Brett Knoblauch raised the firm’s price target on Core Scientific (CORZ) to $26 from $18 and keeps an Overweight rating on the shares. With shareholders set to vote on the proposed acquisition by CoreWeave (CRWV), the firm sees two scenarios should the acquisition get voted down: CoreWeave comes back to the table or Core Scientific continues down the HPC path solo. In either case, it still sees “attractive risk/reward,” the analyst tells investors.
Claim 55% Off TipRanks
Forget margin or options. Here's how the pros trade CORZPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORZ:
- Midday Fly By: Tesla reports mixed Q3, Trump in talks for quantum stakes
- Mixed options sentiment in Core Scientific, Inc with shares down 0.62%
- LendingClub upgraded, Enphase Energy downgraded: Wall Street’s top analyst calls
- Core Scientific upgraded to Buy from Neutral at Roth Capital
- Core Scientific Faces Legal Challenges Over Merger